Certain identified information has been excluded from the exhibit because it is both not material and is of the type that the Company treats as private or confidential. Double asterisks denote omissions.License and Collaboration Agreement • November 7th, 2022 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Ocuphire Pharma Inc., having its corporate offices at 37000 Grand River Avenue, Suite 120, Farmington Hills, Michigan, USA (“Licensor”); and
